Forma Life Science Marketing Blog
|
|||||||||||||||||||||||||
 |  |  |  |  |  |
Email Post
Comments (0)
To Lower Health Care Costs, Ban DTC
March 1, 2010 at 12:10 PM by David ChapinThe old saying: “50% of my advertising works, I just don’t know which half” is actually overly optimistic. When it comes to drug advertising to consumers the real figure may be a lot closer to zero.
read more...
Tags: Advertising DTC
| | | | | |
Email Post
Comments (0)
When Tighter Regulatory Scrutiny Leads to Better Lifescience Marketing, Something is Seriously Wrong
February 11, 2010 at 9:34 AM by David ChapinWhen the FDA monitors marketing claims VERY closely (for example, when marketing a pill, potion or med device) the result can be some very effective marketing (e.g, Advair, Viagra, etc.). On the other hand, there are cases in which the FDA is concerned not with marketing claims but only with the work product (e.g., labs, CROs and service providers that have to submit data to their sponsors and the FDA).
read more...
Tags: Audience CRO Commodity Positioning DTC
| | | | | |
Email Post
Comments (0)
Is DTC Worth the Trouble?
November 23, 2009 at 1:10 PM by David ChapinUS pharmaceutical companies spent an estimated $3 billion on direct-to-consumer (DTC) advertising in 2005.
read more...
Tags: Advertising DTC
| | | | | |
Email Post
Comments (0)
